EffiCacy, Safety and ToLErability of a Novel Ocular ANtiseptic for Ocular Use (CLEAN)

Clinical trial NCT05127525 · TERMINATED

Trial details

NCT number: NCT05127525
Sponsor: iRenix Medical, Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Edema Branch Retinal Vein Occlusion Glaucoma/Closed Angle Glaucoma

Start date: 2021-11-15
Primary completion: 2022-01-31
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.